 |
 |

Autoinflammatory DiseasesClinical and Genetic Advances
Sharifeh Farasat, BS;
Ivona Aksentijevich, MD;
Jorge R. Toro, MD
Arch Dermatol. 2008;144(3):392-402.
We conducted a literature review to investigate the recent advances in genetics, molecular biology, clinical manifestations, and therapy of 7 inherited diseases that are characterized by seemingly unprovoked inflammation. These autoinflammatory diseases include familial Mediterranean fever; tumor necrosis factor receptor–associated periodic syndrome; hyperimmunoglobulinemia D with periodic fever syndrome; pyogenic arthritis, pyoderma gangrenosum, and acne syndrome; and the 3 cryopyrinopathies: neonatal-onset multisystem inflammatory disease/chronic infantile neurologic cutaneous and arthropathy syndrome, familial cold autoinflammatory syndrome, and Muckle-Wells syndrome. Recent identification of the susceptibility genes for autoinflammatory diseases has broadened the clinical spectrum as well as the molecular basis of these diseases. The cryopyrinopathies represent a continuum of diseases associated with mutations in the cold-induced autoinflammatory syndrome 1 (CIAS1) gene that encodes cryopyrin. Cryopyrin and pyrin (protein mutated in familial Mediterranean fever) belong to the family of PYRIN domain–containing proteins. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome is associated with mutations in the gene that encodes for CD2-binding protein 1 (CD2BP1), which binds pyrin. Recent studies have shown that activation of the interleukin 1β pathway is a common mechanism in the pathogenesis of autoinflammatory diseases, further unifying these diseases. Recent advances in genetics and molecular biology have advanced our understanding of the pathogenesis of autoinflammatory diseases. Understanding autoinflammatory diseases will further our knowledge of cutaneous as well as systemic inflammation. Anakinra, a recombinant human interleukin 1 receptor antagonist, is a promising new biologic agent for the treatment of cryopyrinopathies as well other autoinflammatory diseases, such as tumor necrosis factor receptor–associated periodic syndrome and hyperimmunoglobulinemia D with periodic fever syndrome.
Author Affiliations: Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Ms Farasat and Dr Toro); and Genetics and Genomics Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland (Dr Aksentijevich).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Inflammatory cytokine expression in the skin lesions of tumour necrosis factor receptor-associated periodic syndrome
Ohmori et al.
Rheumatology (Oxford) 2012;51:196-199.
FULL TEXT
Successful renal transplantation in Muckle-Wells syndrome treated with anti-IL-1{beta}-monoclonal antibody
Kortus-Gotze and Hoyer
Clin Kidney J 2011;4:404-405.
ABSTRACT
| FULL TEXT
Periodic fever syndrome with relapsing glomerulonephritis: a case report and teaching points
Tsapenko et al.
Clin Kidney J 2011;4:346-351.
ABSTRACT
| FULL TEXT
Translational research network and patient registry for auto-inflammatory diseases
Lainka et al.
Rheumatology (Oxford) 2011;50:237-242.
ABSTRACT
| FULL TEXT
An Autosomal Recessive Syndrome of Joint Contractures, Muscular Atrophy, Microcytic Anemia, and Panniculitis-Associated Lipodystrophy
Garg et al.
J. Clin. Endocrinol. Metab. 2010;95:E58-E63.
ABSTRACT
| FULL TEXT
Reactive oxygen species-independent activation of the IL-1{beta} inflammasome in cells from patients with chronic granulomatous disease
van de Veerdonk et al.
Proc. Natl. Acad. Sci. USA 2010;107:3030-3033.
ABSTRACT
| FULL TEXT
Interleukin-1{beta} (IL-1{beta}) Processing Pathway
Weber et al.
Sci Signal 2010;3:cm2-cm2.
ABSTRACT
| FULL TEXT
Interleukin-1 (IL-1) Pathway
Weber et al.
Sci Signal 2010;3:cm1-cm1.
ABSTRACT
| FULL TEXT
Autoinflammatory diseases
Burge and Wallis
Oxford Handbook of Medical Dermatology 2010;1:med-9780199558322-div1-01-med-9780199558322-div1-01.
FULL TEXT
Tumor Progression Locus 2 (Map3k8) Is Critical for Host Defense against Listeria monocytogenes and IL-1{beta} Production
Mielke et al.
J. Immunol. 2009;183:7984-7993.
ABSTRACT
| FULL TEXT
Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics
Lainka et al.
Rheumatology (Oxford) 2009;48:987-991.
ABSTRACT
| FULL TEXT
|